BioSpace News Archive

PAREXEL International Corporatio announced the appointment of Jamie Macdonald as Chief Executive Officer (CEO) effective March 15, 2018.

Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument

Phase 2 ENCORE 601 PD-(L)1 refractory melanoma cohort data and melanoma registration strategy disclosure forthcoming in 2Q18; ENCORE 601 PD-(L)1 refractory NSCLC cohort data expected 2Q18; Initial data on MSS-CRC cohort of ENCORE 601 to drive decision on advancement into second stage expected in 2Q18; Company to host conference call today at 4:30 p.m. ET

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g.

Alcyon Health LLC’s line of premium, research-based fertility supplements for uncompromising, uncomplicated nutrition to aid in the family planning process is coming soon to health and wellness e-commerce site RevNutrition.com.

Apollo Medical Holdings, Inc. and 42 Interactive, Inc. announced that they will present the results of a study based on ApolloMed ACO patients at the 1st International Conference on Artificial Intelligence in Healthcare.

WallStEquities.com strives to bring the best free research to the investment community is offering reports on PTCT, REGN, RTTR, and SGMO which can be accessed for free by signing up to www.wallstequities.com/registration.

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first automated robotic movement designed for the CorPath GRX platform.

Company adds 100,000 tumors to portfolio; enables broad access to proven technology platform.

Rare Pediatric Disease Designation granted for the treatment of patients with necrotizing enterocolitis (NEC),